Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
JHEP Rep
; 4(2): 100409, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35072021
ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC, area under the receiver operating characteristic; Biomarker; CPM, counts per million; Ct, cycle threshold; ER, endoplasmic reticulum; FC, fold change; FIB-4, fibrosis-4; FLIP, fatty liver inhibition of progression; GTEx, Genotype-Tissue Expression; MicroRNA; NAFL, non-alcoholic fatty liver; NAFLD, non-alcoholic fatty liver disease; NAS, NAFLD activity score; NASH, non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; PCA, principal component analysis; SAF, steatosisactivityfibrosis; Sequencing; TGF-ß, transforming growth factor-beta; cDNA, complementary DNA; logFC, log2 fold change; miRNA, microRNA; qPCR, quantitative PCR
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
JHEP Rep
Year:
2022
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Países Bajos